The relationship between HPV16 and expression of cyclooxygenase-2, P53 and their prognostic roles in esophageal squamous cell carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 1, 2010, Pages 67-74

  Liu, Wen Kang ^a   Jiang, Xiang Yang ^b   Zhang, Mei Ping ^a   Zhang, Zhen Xi ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Correlation; Cyclooxygenase 2; Esophageal squamous cell carcinoma; Human papillomavirus type 16; P53; Prognosis

Indexed keywords

CYCLOOXYGENASE 2; PEROXIDASE; PROTEIN E6; PROTEIN P53; STREPTAVIDIN; VIRUS DNA;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 16 INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RATE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS INFECTION;

CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 74349112625     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32832c7e76     Document Type: Article

References (41)

1. Chang F, Syrjanen S,Wang L, Syrjanen K. Infectious agents in the etiology of esophageal cancer. Gastroenterology 1992; 103:1336-1348.
2. Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Gynecol Oncol 1997; 65:23-29.
3. White AE, Livanos EM, Tlsty TD. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev 1994; 8:666-677.
4. Shen Z, Cen S, Shen J, Cai W, Xu J, Teng Z, et al. Study of immortalization and malignant transformation of human embryonic esophageal epithelial cells induced by HPV18 E6E7. J Cancer Res Clin Oncol 2000; 126:589-594.
5. Shen ZY, Hu SP, Lu LC, Tang CZ, Kuang ZS, Zhong SP, et al. Detection of human papillomavirus in esophageal carcinoma. J Med Virol 2002; 68:412-416.
6. Zhou XB, Guo M, Quan LP, Zhang W, Lu ZM, Wang QH, et al. Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium. World J Gastroenterol 2003; 9:1170-1173.
7. Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002; 55:721-728.
8. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1996; 1299:125-140.
9. Herschman HR. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 1994; 13:241-256.
10. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000; 89:2637-2645.
11. Altorki N. COX-2: a target for prevention and treatment of esophageal cancer. J Surg Res 2004; 117:114-120.
12. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange. Cancer Res 2007; 67:3976-3985.
13. Zhuang ZH, Tsao SW, Deng W, Wang JD, Xia HH, He H, et al. Early upregulation of cyclooxygenase-2 in human papillomavirus type 16 and telomerase-induced immortalization of human esophageal epithelial cells. J Gastroenterol Hepatol 2008; 23:1613-1620.
14. Song SH, Lee JK, Hur JY, Kim I, Saw HS, Park YK. The expression of epidermal growth factor receptor, vascular endothelial growth factor, matrix metalloproteinase-2, and cyclooxygenase-2 in relation to human papilloma viral load and persistence of human papillomavirus after conization with negative margins. Int J Gynecol Cancer 2006; 16:2009-2017.
15. Sarian LO, Derchain SF, Yoshida A, Vassallo J, Pignataro F, De Angelo Andrade LA. Expression of cyclooxygenase-2 (COX-2) and Ki67 as related to disease severity and HPV detection in squamous lesions of the cervix. Gynecol Oncol 2006; 102:537-541.
16. Saldivar JS, Lopez D, Feldman RA, Tharappel-Jacob R, de la Rosa A, Terreros D, et al. COX-2 overexpression as a biomarker of early cervical carcinogenesis: a pilot study. Gynecol Oncol 2007; 107:S155-S162.
17. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ. Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem 1999; 274:10911-10915.
18. Liu YS, Yu CH, Li L, Zhang BF, Fang J, Zhou Q, et al. Expression of p53, p16 and cyclooxygenase-2 in esophageal cancer with tissue microarray. J Dig Dis 2007; 8:133-138.
19. Lu XM, Zhang YM, Lin RY, Liang XH, Zhang YL, Wang X, et al. p53 polymorphism in human papillomavirus-associated Kazakh's esophageal cancer in Xinjiang, China. World J Gastroenterol 2004; 10:2775-2778.
20. Kawaguchi H, Ohno S, Araki K, Miyazaki M, Saeki H, Watanabe M, et al. p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res 2000; 60:2753-2755.
21. Li T, Lu ZM, Guo M, Wu QJ, Chen KN, Xing HP, et al. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 2002; 95:2571-2576.
22. Yang W, Zhang Y, Tian X, Ning T, Ke Y. p53 codon 72 polymorphism and the risk of esophageal squamous cell carcinoma. Mol Carcinog 2008; 47:100-104. (Pubitemid 351231438)
23. Hasegawa M, Ohoka I, Yamazaki K, Hanami K, Sugano I, Nagao T, et al. Expression of p21/WAF-1, status of apoptosis and p53 mutation in esophageal squamous cell carcinoma with HPV infection. Pathol Int 2002; 52:442-450.
24. Gall K, Pavicic D, Pavelic J, Audy-Jurkovic S, Pavelic K. PCR amplification of DNA from stained cytological smears. J Clin Pathol 1993; 46:378-379.
25. Zhi H,Wang L, Zhang J, Zhou C, Ding F, Luo A, et al. Significance of COX-2 expression in human esophageal squamous cell carcinoma. Carcinogenesis 2006; 27:1214-1221. (Pubitemid 43985436)
26. Xu H, Lu DW, El-Mofty SK,Wang HL. Metachronous squamous cell carcinomas evolving from independent oropharyngeal and pulmonary squamous papillomas: association with human papillomavirus 11 and lack of aberrant p53, Rb, and p16 protein expression. Hum Pathol 2004; 35:1419-1422.
27. Shuyama K, Castillo A, Aguayo F, Sun Q, Khan N, Koriyama C, et al. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer 2007; 96:1554-1559.
28. Li T, Lu ZM, Chen KN, Guo M, Xing HP, Mei Q, et al. Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis 2001; 22:929-934.
29. Sur M, Cooper K. The role of the human papilloma virus in esophageal cancer. Pathology 1998; 30:348-354.
30. Zhu LZ, Su XL, Chen KN, Yang RJ, Xing HP, Cui JG, et al. Detection rate of human papillomavirus-16 in esophageal squamous cell carcinoma from different Chinese populations. Ai Zheng 2005; 24:870-873.
31. Lu Z, Chen K, Guo M. Detection of HPV in human esophageal cancer in high-incidence area and its correlation with p53 expression. Zhonghua Zhong Liu Za Zhi 2001; 23:220-223.
32. Xu WG, Zhang LJ, Lu ZM, Li JY, Ke Y, Xu GW. Detection of human papillomavirus type 16 E6 mRNA in carcinomas of upper digestive tract. Zhonghua Yi Xue Za Zhi 2003; 83:1910-1914.
33. Xu CL, Qian XL, Zhou XS, Zhao QZ, Li YC. Expression of HPV16-E6 and E7 oncoproteins in squamous cell carcinoma tissues of esophageal cancer and non-cancer tissues. Ai Zheng 2004; 23:165-168.
34. Poljak M, Cerar A, Seme K. Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. Hum Pathol 1998; 29:266-271.
35. Lavergne D, de Villiers EM. Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 1999; 80:681-684.
36. Gao GF, Roth MJ,Wei WQ, Abnet CC, Chen F, Lu N, et al. No association between HPV infection and the neoplastic progression of esophageal squamous cell carcinoma: result from a cross-sectional study in a high-risk region of China. Int J Cancer 2006; 119:1354-1359.
37. He D, Zhang DK, Lam KY, Ma L, Ngan HY, Liu SS, et al. Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 1997; 72:959-964. (Pubitemid 27433558)
38. Taylor PR, Qiao YL, Abnet CC, Dawsey SM, Yang CS, Gunter EW, et al. Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst 2003; 95:1414-1416.
39. Haas AR, Sun J, Vachani A, Wallace AF, Silverberg M, Kapoor V, et al. Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine. Clin Cancer Res 2006; 12:214-222.
40. Ryan EP, Malboeuf CM, Bernard M, Rose RC, Phipps RP. Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particles. J Immunol 2006; 177:7811-7819.
41. Zhang W, Wang L, Chang A, Jin Y, Rao J. Immunohistochemical analysis of cyclooxygenase-2 expression in premalignant and malignant esophageal glandular and squamous lesions in Cixian, China. Cancer Detect Prev 2003; 27:243-249.